# | Title | Journal | Year | Citations |
---|
|
1 | High-Resolution Imaging Methods for Identification of Calcium Crystal Types in Osteoarthritis | Gout, Urate, and Crystal Deposition Disease | 2023 | 7 |
2 | Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies | Gout, Urate, and Crystal Deposition Disease | 2023 | 7 |
3 | The Gouty Kidney: A Reappraisal | Gout, Urate, and Crystal Deposition Disease | 2023 | 5 |
4 | Crystal Clear? The 2022 NICE Guideline for the Diagnosis and Management of Gout | Gout, Urate, and Crystal Deposition Disease | 2023 | 4 |
5 | The Risk of Cardiovascular Disease among Male and Female Participants Treated for Gout in the Multi-Ethnic Study of Atherosclerosis (MESA) | Gout, Urate, and Crystal Deposition Disease | 2023 | 3 |
6 | Optimizing the Use of Ultrasound in Calcium Pyrophosphate Deposition (CPPD): A Review from the Ground Up | Gout, Urate, and Crystal Deposition Disease | 2024 | 3 |
7 | Year in Review: Gout Clinical Research | Gout, Urate, and Crystal Deposition Disease | 2023 | 2 |
8 | Atherogenic Activation of Human Vascular Smooth Muscle Cells by Monosodium Urate Crystals | Gout, Urate, and Crystal Deposition Disease | 2023 | 2 |
9 | Does Monosodium Urate Crystal Vascular Deposition Exist? Review of the Evidence | Gout, Urate, and Crystal Deposition Disease | 2023 | 2 |
10 | Gout in Paleopathology: A Review with Some Etiological Considerations | Gout, Urate, and Crystal Deposition Disease | 2023 | 2 |
11 | A New Era for Calcium Pyrophosphate Deposition Disease Research: The First-Ever Calcium Pyrophosphate Deposition Disease Classification Criteria and Considerations for Measuring Outcomes in Calcium Pyrophosphate Deposition Disease | Gout, Urate, and Crystal Deposition Disease | 2024 | 2 |
12 | Calcium Pyrophosphate and Basic Calcium Phosphate Crystal Arthritis: 2023 in Review | Gout, Urate, and Crystal Deposition Disease | 2024 | 2 |
13 | Colchicine Use and Major Adverse Cardiovascular Events in Male Patients with Gout and Established Coronary Artery Disease: A Veterans Affairs Nested Retrospective Cohort Study | Gout, Urate, and Crystal Deposition Disease | 2023 | 1 |
14 | Metabolomics in Hyperuricemia and Gout | Gout, Urate, and Crystal Deposition Disease | 2023 | 1 |
15 | Ultrasound Findings of Monosodium Urate Aggregates in Patients with Gout | Gout, Urate, and Crystal Deposition Disease | 2023 | 1 |
16 | What Drives the Contemporary Black–White Racial Disparities in Gout in the US? Impact of Social Determinants of Health | Gout, Urate, and Crystal Deposition Disease | 2023 | 1 |
17 | Proteoglycan 4 (PRG4)/Lubricin and the Extracellular Matrix in Gout | Gout, Urate, and Crystal Deposition Disease | 2023 | 1 |
18 | Epigenetic and Metabolic Regulation of Macrophages during Gout | Gout, Urate, and Crystal Deposition Disease | 2023 | 1 |
19 | Calcium Pyrophosphate and Basic Calcium Phosphate Deposition Diseases: The Year in Review 2022 | Gout, Urate, and Crystal Deposition Disease | 2023 | 1 |
20 | The Prevalence of Titanium Dioxide Particles in Synovial Fluid Samples Drops after European Union Ban | Gout, Urate, and Crystal Deposition Disease | 2024 | 1 |
21 | Gout, Urate, and Crystal Deposition Disease: Launch of the First Journal Dedicated to a Rapidly Growing Field | Gout, Urate, and Crystal Deposition Disease | 2023 | 0 |
22 | Urate Biology and Biochemistry: A Year in Review 2022 | Gout, Urate, and Crystal Deposition Disease | 2023 | 0 |
23 | The Evolving Landscape of Gout in the Female: A Narrative Review | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
24 | Imaging Follow-Up of MSU Crystal Depletion | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
25 | Serum Urate as a Surrogate Outcome for Gout Flares: Where Do We Stand Today? | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
26 | Prevalence and Influence of Gout in Patients with Advanced Chronic Kidney Disease: Findings of a Large Retrospective Chart Review | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
27 | Optimising the Use of Ultrasound in Gout: A Review from the Ground Up | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
28 | Circadian Rhythms in NLRP3 Inflammasome Regulation: Possible Implications for the Nighttime Risk of Gout Flares | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
29 | Sex-Specific Differences in Cytokine Production Capacity in Patients with Gout Compared to Controls | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
30 | Gout and Gout-Related Comorbidities: Insight and Limitations from Population-Based Registers in Sweden | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
31 | SGLT2 Inhibitors and Uric Acid Homeostasis | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
32 | Regulation of Urate Homeostasis by Membrane Transporters | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
33 | Gout Basic Research: 2023 in Review | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
34 | Age-Associated Calcification: Insights from Murine Models | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
35 | Obesity-Associated Hyperuricemia in Female Mice: A Reevaluation | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |
36 | Periarticular Calcifications: Clinical Features and Treatment Options | Gout, Urate, and Crystal Deposition Disease | 2024 | 0 |